Literature DB >> 8760018

Nasopharyngeal lymphomas: further evidence for a natural killer cell origin.

T Petrella1, M H Delfau-Larue, D Caillot, J L Morcillo, O Casasnovas, H Portier, P Gaulard, J P Farcet, L Arnould.   

Abstract

The authors report four cases of sinonasal lymphomas with immunophenotypic (four cases) and genotypic (three cases) studies. These lymphomas are frequent in Oriental countries, but unusual in Western populations, particularly in France. Although they have been originally considered as T-cell lymphomas, their origin remains unclear, and several authors have recently suggested that they are a natural killer (NK)-cell proliferation. The tumor cells of the four cases reported here showed characteristics of NK cells. On cryostat sections, they were CD3 negative, but CD2 and CD56 positive. The cytoplasm of the tumor cells exhibited azurophilic granulations. Using polymerase chain reaction (PCR), no clonal rearrangement of the T-cell receptor gamma gene was present. Furthermore, clinically, two presented a pharyngeal involvement, and two were also characterized by hepatosplenic involvement at the time of the diagnosis. Thus, the present cases provide additional evidence toward the NK-cell origin of these rare lymphomas. Many sinonasal lymphomas, including the present cases, are positive for Epstein-Barr virus (EBV) (LMP-1 antibody and EBER-messenger RNA probes). This may suggest an important role of EBV as a local factor in their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760018     DOI: 10.1016/s0046-8177(96)90457-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  1 in total

1.  Cardiac Involvement and Subsequent Death due to Extranodal NK/T Cell Cutaneous T-Cell Lymphoma: An Autopsy Case and Brief Review of the Literature.

Authors:  Nikolaos D Goutas; Emmanouil I Sakelliadis; Eleftheria Lakiotaki; Konstantinos D Katsos; Kalliroi Spanou; Pinelopi Korkolopoulou; Dimitrios G Vlachodimitropoulos
Journal:  Iran J Pathol       Date:  2020-06-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.